Chemical Structure : SCIO-469
CAS No.: 309913-83-5
货号: PC-42566Not For Human Use, Lab Use Only.
Talmapimod (SCIO469) is a potent, selective p38α MAPK inhibitor with IC50 of 9 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1280 | In stock | |
10 mg | ¥1980 | In stock | |
25 mg | ¥2980 | In stock | |
50 mg | ¥4580 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Talmapimod (SCIO469) is a potent, selective p38α MAPK inhibitor with IC50 of 9 nM.
Talmapimod (SCIO469) displays 10-fold selectivity for p38α over p38β, >2,000-fold selectivity over a panel of 20 other kinases, including other MAP kinases.
Talmapimod (SCIO469) decreases apoptosis in MDS CD34+ progenitors and leads to dose-dependant increases in erythroid and myeloid colony formation.
Talmapimod (SCIO469) enhances the ability of MG132 and bortezomib to induce the apoptosis of MM cells, and inhibits tumor growth in vivo.
分子量 | 513.0035 | |
分子式 | C27H30ClFN4O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1H-Indole-3-acetamide, 6-chloro-5-[[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-N,N,1-trimethyl-α-oxo- |
1. Navas TA, et al. Leukemia. 2006 Jun;20(6):1017-27.
2. Navas TA, et al. Blood. 2006 Dec 15;108(13):4170-7.
3. Hideshima T, et al. Oncogene. 2004 Nov 18;23(54):8766-76.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright